FDA Approved: TRAZIMERA — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

FDA approved a supplemental application for TRAZIMERA (trastuzumab-qyyp) from Pfizer Laboratories Div Pfizer Inc, authorizing changes under the biosimilar trast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Gastric Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• TRAZIMERA (TRASTUZUMAB-QYYP)

Snippet

SUPPL AP for TRAZIMERA (TRASTUZUMAB-QYYP)